Voyageur Pharmaceuticals Ltd. (VM.V)
CAD 0.11
(50.0%)
CAD 0.11
(50.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.01 CAD | 34.36% |
| 2022 | -0.02 CAD | 24.88% |
| 2021 | -0.02 CAD | -33.95% |
| 2020 | -0.02 CAD | -68.75% |
| 2019 | -0.01 CAD | 17.95% |
| 2018 | -0.01 CAD | 36.41% |
| 2017 | -0.02 CAD | 64.55% |
| 2016 | -0.05 CAD | -3360.0% |
| 2015 | -0.00 CAD | 98.4% |
| 2014 | -0.09 CAD | -108.44% |
| 2013 | -0.04 CAD | 67.86% |
| 2012 | -0.14 CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.00 CAD | -60.0% |
| 2024 Q1 | -0.00 CAD | -19.05% |
| 2024 Q3 | -0.00 CAD | 35.0% |
| 2023 Q2 | -0.00 CAD | -56.67% |
| 2023 Q3 | -0.00 CAD | 78.72% |
| 2023 FY | - CAD | 34.36% |
| 2023 Q4 | -0.00 CAD | -110.0% |
| 2023 Q1 | -0.00 CAD | 40.0% |
| 2022 Q3 | -0.00 CAD | 21.28% |
| 2022 Q1 | -0.00 CAD | 52.94% |
| 2022 Q2 | -0.00 CAD | -95.83% |
| 2022 Q4 | -0.01 CAD | -35.14% |
| 2022 FY | - CAD | 24.88% |
| 2021 Q1 | -0.00 CAD | 50.0% |
| 2021 FY | - CAD | -33.95% |
| 2021 Q4 | -0.01 CAD | -21.43% |
| 2021 Q2 | -0.00 CAD | -236.36% |
| 2021 Q3 | -0.00 CAD | -13.51% |
| 2020 Q4 | -0.00 CAD | 48.84% |
| 2020 Q3 | -0.00 CAD | -10.26% |
| 2020 Q1 | -0.01 CAD | -306.67% |
| 2020 FY | - CAD | -68.75% |
| 2020 Q2 | -0.00 CAD | 36.07% |
| 2019 Q2 | -0.00 CAD | 25.93% |
| 2019 Q4 | -0.00 CAD | 58.33% |
| 2019 Q3 | -0.00 CAD | -80.0% |
| 2019 FY | - CAD | 17.95% |
| 2019 Q1 | -0.00 CAD | 61.43% |
| 2018 FY | - CAD | 36.41% |
| 2018 Q1 | -0.00 CAD | 13.16% |
| 2018 Q2 | -0.00 CAD | -3.03% |
| 2018 Q3 | 0.00 CAD | 147.06% |
| 2018 Q4 | -0.01 CAD | -537.5% |
| 2017 Q1 | -0.00 CAD | -50.0% |
| 2017 Q3 | -0.01 CAD | 29.33% |
| 2017 FY | - CAD | 64.55% |
| 2017 Q4 | -0.00 CAD | 28.3% |
| 2017 Q2 | -0.01 CAD | -400.0% |
| 2016 Q1 | -0.00 CAD | 78.85% |
| 2016 Q2 | -0.01 CAD | -509.09% |
| 2016 Q3 | -0.00 CAD | 64.18% |
| 2016 Q4 | -0.00 CAD | 58.33% |
| 2016 FY | - CAD | -3360.0% |
| 2015 Q1 | -0.00 CAD | 0.0% |
| 2015 FY | - CAD | 98.4% |
| 2015 Q4 | -0.01 CAD | -1200.0% |
| 2015 Q2 | 0.02 CAD | 600.0% |
| 2015 Q3 | -0.00 CAD | -102.0% |
| 2014 Q1 | -0.01 CAD | 82.44% |
| 2014 FY | - CAD | -108.44% |
| 2014 Q4 | - CAD | 100.0% |
| 2014 Q3 | -0.00 CAD | 91.56% |
| 2014 Q2 | -0.05 CAD | -723.73% |
| 2013 Q3 | -0.00 CAD | 51.35% |
| 2013 Q4 | -0.03 CAD | -1766.67% |
| 2013 Q2 | -0.00 CAD | 37.29% |
| 2013 Q1 | -0.01 CAD | 0.0% |
| 2013 FY | - CAD | 67.86% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 100.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q2 | -0.02 CAD | 0.0% |
| 2012 Q3 | -0.01 CAD | 66.32% |
| 2011 FY | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -0.02 CAD | 52.232% |
| CanadaBis Capital Inc. | 0.03 CAD | 133.025% |
| Decibel Cannabis Company Inc. | -0.00 CAD | -148.837% |
| Delivra Health Brands Inc. | 0.00 CAD | 445.161% |
| Entourage Health Corp. | -0.15 CAD | 92.867% |
| Lifeist Wellness Inc. | -0.58 CAD | 98.155% |
| Cannara Biotech Inc. | 0.08 CAD | 113.753% |
| Medicure Inc. | -0.09 CAD | 87.882% |
| PharmaCielo Ltd. | -0.10 CAD | 89.3% |
| Rubicon Organics Inc. | -0.03 CAD | 66.873% |
| BioSyent Inc. | 0.54 CAD | 101.981% |